🔗 Share this article

Texas Attorney General Paxton is suing the producers of acetaminophen, alleging the companies hid alleged dangers that the drug created to pediatric neurological development.

The lawsuit comes four weeks after President Donald Trump promoted an unverified association between using Tylenol - alternatively called acetaminophen - throughout gestation and autism in young ones.

The attorney general is filing suit against Johnson & Johnson, which once produced the drug, the exclusive pain medication suggested for pregnant women, and Kenvue, which presently makes it.

In a official comment, he stated they "deceived the public by profiting off of pain and marketing drugs regardless of the risks."

Kenvue states there is lacking scientific proof linking Tylenol to autism.

"These companies misled for generations, intentionally threatening numerous people to line their pockets," Paxton, from the Republican party, declared.

The manufacturer stated officially that it was "deeply concerned by the dissemination of inaccurate information on the reliability of paracetamol and the likely effects that could have on the well-being of women and children in America."

On its online platform, the company also mentioned it had "consistently assessed the applicable studies and there is no credible data that demonstrates a proven link between taking acetaminophen and autism."

Organizations acting on behalf of doctors and medical practitioners agree.

The leading OB-GYN organization has declared paracetamol - the key substance in acetaminophen - is a restricted selection for pregnant women to manage discomfort and elevated temperature, which can create significant medical dangers if left untreated.

"In over twenty years of research on the utilization of paracetamol in pregnancy, not a single reputable study has definitively established that the use of paracetamol in any trimester of pregnancy causes brain development issues in children," the association commented.

The lawsuit references current declarations from the Trump administration in asserting the drug is reportedly hazardous.

Recently, Trump generated worry from health experts when he told expectant mothers to "fight like hell" not to consume Tylenol when ill.

The FDA then published an announcement that medical professionals should consider limiting the usage of Tylenol, while also mentioning that "a direct connection" between the medication and autism in children has remains unverified.

The Health Department head Kennedy, who oversees the FDA, had vowed in spring to undertake "comprehensive study program" that would determine the cause of autism spectrum disorder in a short period.

But authorities warned that identifying a single cause of autism - thought by researchers to be the result of a complex mix of inherited and environmental factors - would not be simple.

Autism is a category of lifelong neurodivergence and impairment that impacts how individuals experience and relate to the world, and is recognized using medical professional evaluations.

In his legal document, the attorney general - a Trump ally who is running for federal office - asserts the manufacturer and Johnson & Johnson "intentionally overlooked and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the companies "remove any commercial messaging" that states Tylenol is safe for expectant mothers.

This legal action mirrors the grievances of a assembly of parents of minors with autism and ADHD who filed suit against the makers of Tylenol in recently.

Judicial authorities dismissed the lawsuit, declaring studies from the family's specialists was lacking definitive proof.